TriSalus Life Sciences, Inc. TLSI Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $20.79M+134% | $8.88M-26.8% | $12.13M+25.5% | $9.66M-68.1% | ||
| $22.58M+18.9% | $19M+164% | $7.19M+311% | $1.75M— | ||
| $3.08M-24.0% | $4.05M+59.1% | $2.55M+73.0% | $1.47M— | ||
| $32.24M+56.0% | $20.67M-0.9% | $20.86M+21.2% | $17.21M+3,173% | ||
| $1.81M+8.3% | $1.67M-20.2% | $2.09M-6.3% | $2.23M— | ||
| $35.33M+47.4% | $23.97M-2.5% | $24.6M+11.8% | $22M-91.2% | ||
| $3M+32.0% | $2.27M-32.9% | $3.39M-31.5% | $4.95M+368% | ||
| $11.5M+12.4% | $10.23M-30.4% | $14.69M-54.6% | $32.36M+1,920% | ||
| $33.05M+49.6% | $22.08M— | $0— | —— | ||
| $69.19M+38.8% | $49.87M-3.5% | $51.66M+50.5% | $34.32M+98.9% | ||
| 400M+13,333,233% | 3K+50.0% | 2K— | 0— | ||
| -$330.58M-18.3% | -$279.55M-12.0% | -$249.5M-33.9% | -$186.36M-1,015% | ||
| -$33.86M-30.8% | -$25.89M+4.3% | -$27.07M+84.7% | -$177.13M-36.7% | ||
| $35.33M+47.4% | $23.97M-2.5% | $24.6M+11.8% | $22M-91.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are TriSalus Life Sciences, Inc.'s total assets?
- TriSalus Life Sciences, Inc. (TLSI) holds $71.0M in total assets, up 148.0% year over year.
- How much debt does TriSalus Life Sciences, Inc. have?
- TriSalus Life Sciences, Inc. carries $33.1M in total debt against $12.8M of shareholders' equity, a debt-to-equity ratio of 2.58.
- How much cash does TriSalus Life Sciences, Inc. have?
- TriSalus Life Sciences, Inc. holds $56.6M in cash and equivalents.
- Can TriSalus Life Sciences, Inc. cover its short-term obligations?
- Its current ratio is 5.78 — current assets exceed current liabilities.
- Where does TriSalus Life Sciences, Inc.'s balance sheet data come from?
- Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
